Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
How orphan designated drugs M&A performed in the pharmaceutical industry in Q3 2024
Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 22 pharmaceutical deals announced in...
How orphan designated drugs private equity performed in the pharmaceutical industry in Q3 2024
Analysis of the key themes driving private equity deal activity reveals that orphan designated drugs accounted for two pharmaceutical deals...
How did the pharmaceutical industry treat orphan designated drugs in Q2 2024 filings?
The global pharmaceutical industry experienced a 7% drop in company filings mentions of orphan designated drugs in Q2 2024 compared...
Who’s posting what? Orphan Designated Drugs related social media posts increased by 9% in the pharma industry in Q1 2023
The global pharma industry experienced a 9% rise in social media posts on orphan designated drugs in Q1 2023 compared...